NL-OMON39807已完成不适用
[18F]-labelled FDHT in PET/CT for detection and staging of bone metastases in hormone naïve prostate cancer - [18F]FDHT PET/CT in hormone naive prostate cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Men, fifty years or older, with metastasized prostate cancer, confirmed by positive bone scan, suspicious lesions >=2 in bone, who have not been treated with androgen deprivation therapy yet. The men cannot have another malignancy and they have to have given informed consent.
排除标准
- •active cancer besides prostate cancer
- •no written informed consent
- •previous androgen deprivation therapy
- •Age below 50
- •imminent pathological fractures or spinal cord lesions as a result of metastases that reqiure immediate start of androgen deprivation therapy
研究者
相似试验
进行中（未招募）
不适用
Detection and staging of bone metastases in prostate cancer, not yet been treated with hormones, using labelled testosterone in PET/CT.Hormone naive prostate cancer, metastasized to bone (2 or more bone metastases).EUCTR2013-002415-10-NLniversity Medical Center Groningen
Unknown
不适用
Het vaststellen van botmetastases in hormoon naïeve prostaatkanker in PET/CT met behulp van [18F]FDHThormone naive prostate cancer metastasized to bone, hormoon naïve bot-gemetastaseerde prostaatkankerNL-OMON27460MCG
尚未招募
不适用
To study the role of FDG PET-CT in patients with lower back spinal pain for localization of active site generating pain and causing pain symptoms.CTRI/2022/09/046021ot applicable
已完成
3 期
Evaluation of 18F-FDHT PET/CT as a predictor of response in patients with metastasized castration-resistant prostate cancer to be treated with enzalutamide.10027476Prostate cancerNL-OMON41464niversitair Medisch Centrum Groningen60
招募中
不适用
[18F]Fluoride PET-CT imaging for detection and monitoring of bone formation in spondyloarthritisNL-OMON52517Vrije Universiteit Medisch Centrum48